Interestingly, PLCH patients showed significant higher levels of CCL17 compared to IPF and SR-ILD, suggesting a role for CCL17 in PLCH and probably reflecting a biased response toward an alternative activation of inflammatory cells. The gene discussed is CCL17; the disease is interstitial lung disease.